A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with some waiting up to six months for a diagnosis.

—Data from this real-world study revealed that patients with MS being treated with DMTs had a disproportionally higher number of cases of herpes zoster compared with patients treated with other ...

Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...

NATIONAL HARBOR, Maryland — Though evidence is mounting that low vitamin D levels may increase risk for the development and perhaps progression of multiple sclerosis, clinicians still do not have ...

Olfactory dysfunction in MS may be linked to nasal microbial changes, not just central inflammation. MS patients showed lower ...